Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY36.52 CNY
Change Today -0.53 / -1.43%
Volume 3.2M
600976 On Other Exchanges
Symbol
Exchange
Shanghai
As of 3:05 AM 04/30/15 All times are local (Market data is delayed by at least 15 minutes).

jianmin pharmaceutical gro-a (600976) Snapshot

Open
CNY37.18
Previous Close
CNY37.05
Day High
CNY37.20
Day Low
CNY36.35
52 Week High
04/22/15 - CNY40.18
52 Week Low
05/19/14 - CNY18.58
Market Cap
5.6B
Average Volume 10 Days
5.7M
EPS TTM
CNY0.75
Shares Outstanding
153.4M
EX-Date
05/8/15
P/E TM
48.9x
Dividend
CNY0.38
Dividend Yield
1.04%
Current Stock Chart for JIANMIN PHARMACEUTICAL GRO-A (600976)

Related News

No related news articles were found.

jianmin pharmaceutical gro-a (600976) Related Businessweek News

No Related Businessweek News Found

jianmin pharmaceutical gro-a (600976) Details

Wuhan Jianmin Pharmaceutical Group Co., Ltd. engages in the research and development, production, and sale of pharmaceuticals primarily in China. The company provides granule drugs for the prevention and cure of child calcium deficiency; and tablet drugs for the treatment of faucitis and throat protection, as well as drugs for enhancing blood generation. It also operates drug stores. The company is based in Wuhan, China.

jianmin pharmaceutical gro-a (600976) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

jianmin pharmaceutical gro-a (600976) Key Developments

Jianmin Pharmaceutical Groups Corp., Ltd Announces Earnings Results for the First Quarter of 2015

Jianmin Pharmaceutical Groups Corp., Ltd. announced earnings results for the first quarter of 2015. For the year, the company reported basic earnings per share of CNY 0.17 and weighted average return on net assets of 2.59%.

Wuhan Jianmin Pharmaceutical Group Co., Ltd. Approves Amendments to the Articles of Association

Wuhan Jianmin Pharmaceutical Group Co., Ltd. approved amendments to the articles of association of the company at its AGM held on April 03, 2015.

Wuhan Jianmin Pharmaceutical Group Co., Ltd. Approves Cash Dividend, Payable on May 8, 2015

Wuhan Jianmin Pharmaceutical Group Co. Ltd. announced at its Annual General Meeting held on 03 April 2015, the shareholders approve the cash dividend of CNY 3.8 for every ten shares (tax included) of the company. Record date is on May 7, 2015 with ex-dividend date is on May 8, 2015 and payable on May 8, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600976:CH CNY36.52 CNY -0.53

600976 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 600976.
View Industry Companies
 

Industry Analysis

600976

Industry Average

Valuation 600976 Industry Range
Price/Earnings 48.1x
Price/Sales 3.2x
Price/Book 5.8x
Price/Cash Flow 48.4x
TEV/Sales 2.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact JIANMIN PHARMACEUTICAL GRO-A, please visit www.whjm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.